This is consistent with findings from previous literature showing that the inhibition of XBP1 activity reduced NLRP3 inflammasome assembly and caspase-1 processing in a model of hepatic ischemia-reperfusion, thus reducing IRI-triggered liver injury [33, 34]. The gene discussed is CASP1; the disease is injury.